| ID | Name | CAS |
MW (g/mol) |
| 25-827-6 |
3,16,17-Trihydroxy-5-abdrosten-11-one, tris-TMS
|
| 536.97 |
| 52-813-1 |
Silane, diethyl(dodec-9-ynyloxy)octadecyloxy-
|
| 536.99 |
| 78-059-1 |
Nonyl octacosyl ether
|
| 537.00 |
| 73-468-2 |
Heptyl triacontyl ether
|
| 537.00 |
| 78-058-2 |
Propyl tetratriacontyl ether
|
| 537.00 |
| 57-449-1 |
2,4,6-Tris(2-fluoro-2,2-dinitroethoxy)-1,3,5-triazine
|
28820-59-9 | 537.19 |
| 37-375-5 |
4-[2-Bis(trifluoroacetyl)amino-1-(trifluoroacetyloxy)ethyl]phenyl trifluoroacetate
|
| 537.21 |
| 94-706-4 |
Nickel-1,3,5,7-tetramethyl-2,4,6,8-tetraethylporphyrine complex
|
| 537.36 |
| 123-439-8 |
Benzamide, 3-fluoro-4-trifluoromethyl-N-(3-fluoro-4-trifluoromethylbenzoyl)-N-decyl-
|
| 537.49 |
| 123-219-2 |
Benzamide, 3-trifluoromethyl-2-fluoro-N-(3-trifluoromethyl-2-fluorobenzoyl)-N-decyl-
|
| 537.49 |
| 113-581-1 |
Benzamide, 3-fluoro-5-trifluoromethyl-N-(3-fluoro-5-trifluoromethylbenzoyl)-N-decyl-
|
| 537.49 |
| 72-107-3 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, dodecyl ester
|
| 537.58 |
| 10-326-8 |
l-Isoleucine, n-heptafluorobutyryl-, pentadecyl ester
|
| 537.59 |
| 118-351-1 |
Sarcosine, n-heptafluorobutyryl-, octadecyl ester
|
| 537.59 |
| 33-258-9 |
«beta»-Alanine, n-heptafluorobutyryl-, octadecyl ester
|
| 537.59 |
| 57-324-9 |
l-Valine, n-heptafluorobutyryl-, hexadecyl ester
|
| 537.59 |
| 59-043-9 |
l-Leucine, n-heptafluorobutyryl-, pentadecyl ester
|
| 537.59 |
| 123-276-9 |
m-Octopamine, N-DTFMB-TMS
|
| 537.64 |
| 12-898-2 |
p-Octopamine, DTFMB-TMS
|
| 537.64 |
| 118-704-9 |
Dopamine, N-DTFMB-TMS
|
| 537.64 |
| 37-588-9 |
Tetraheptylammonium iodide
|
3535-83-9 | 537.69 |
| 98-997-8 |
DL-Alanine, N-methyl-N-((1R)-(-)-menthyloxycarbonyl)-, octadecyl ester
|
| 537.86 |
| 97-229-1 |
L-Leucine, N-methyl-N-((1R)-(-)-menthyloxycarbonyl)-, pentadecyl ester
|
| 537.86 |
| 25-160-6 |
3«alpha»,11«beta»-dihydroxy-5«beta»-androstan-17-one, MO-TMS
|
| 538.00 |
| 29-592-3 |
3«alpha»,11«beta»-dihydroxy-5«alpha»-androstan-17-one, MO-TMS
|
| 538.00 |
| 13-805-3 |
3«alpha»,16«alpha»-dihydroxy-5«beta»-androstan-17-one, MO-TMS, (syn,anti)
|
| 538.00 |
| 70-124-6 |
3«beta»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, MO-TMS
|
| 538.00 |
| 50-836-8 |
3«alpha»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, MO-TMS, (syn,anti)
|
| 538.00 |
| 43-391-0 |
decane, docosafluoro-
|
307-45-9 | 538.07 |
| 26-905-8 |
Perfluoro-2,7-dimethyloctane
|
3021-63-4 | 538.07 |
| 96-566-8 |
Succinic acid, di(2-(pentafluorophenoxy)ethyl) ester
|
| 538.29 |
| 114-432-5 |
Diethylmalonic acid, 2,2,3,3,4,4,4-heptafluorobutyl tetradecyl ester
|
| 538.58 |
| 123-794-4 |
Succinic acid, heptadecyl 2,2,3,3,4,4,4-heptafluorobutyl ester
|
| 538.58 |
| 24-209-3 |
«alpha»-Hydroxyarachidic acid, HFB-Me
|
| 538.58 |
| 47-538-3 |
Glutaric acid, 2,2,3,3,4,4,4-heptafluorobutyl hexadecyl ester
|
| 538.58 |
| 59-468-8 |
Phthalic acid, pentadecyl 2,3,4,5-tetrafluorobenzyl ester
|
| 538.61 |
| 74-628-3 |
2,5-Di(trifluoromethyl)benzoic acid, eicosyl ester
|
| 538.65 |
| 118-669-9 |
Glutaric acid, 2,5-difluorobenzyl eicosyl ester
|
| 538.75 |
| 35-104-7 |
Diethylmalonic acid, 3,4-difluorobenzyl octadecyl ester
|
| 538.75 |
| 72-138-9 |
2-(2-(2-(2-(2-(2-(2-decyloxy-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethanol, TMS
|
| 538.83 |
| 68-487-7 |
Methyl «alpha»-D-glucopyranose, 3,4-bis-O-pentyloxymethyl ether, TMS
|
| 538.86 |
| 33-190-4 |
16«beta»,17-H2(OH)2 GA12, MeTMSi
|
| 538.86 |
| 37-688-8 |
GA83, MeTMS
|
| 538.86 |
| 65-989-3 |
16,17-Dihydro-17-OH-GA53 methyl ester TMS ether
|
| 538.86 |
| 24-159-9 |
16«alpha», 17-H2-OH GA53, methyl ester TMS ether
|
| 538.86 |
| 42-339-9 |
GA42, MeTMS
|
| 538.86 |
| 67-182-6 |
16«alpha»,17-H2(OH)2 GA12, MeTMSi
|
| 538.86 |
| 70-993-2 |
17-OH-16«beta»,17-H2 GA53 methyl ester TMS ether
|
| 538.86 |
| 88-297-6 |
Sebacic acid, hexadecyl oct-3-yl ester
|
| 538.89 |
| 63-639-3 |
Hexadecanoic acid, 1,2-ethanediyl ester
|
624-03-3 | 538.89 |
| 57-493-2 |
Diethylmalonic acid, 3,7-dimethyloctyl heptadecyl ester
|
| 538.89 |
| 23-359-8 |
Diethylmalonic acid, dodecyl pentadecyl ester
|
| 538.89 |
| 57-238-5 |
Dimethylmalonic acid, octadecyl undecyl ester
|
| 538.89 |
| 81-512-3 |
didodecyl sebacate
|
2432-88-4 | 538.89 |
| 24-985-2 |
Diethylmalonic acid, nonyl octadecyl ester
|
| 538.89 |
| 98-903-1 |
Silane, diphenyl(4-heptyloxy)hexadecyloxy-
|
| 538.92 |
| 98-902-2 |
Silane, diphenylheptadecyloxy(hex-3-yloxy)-
|
| 538.92 |
| 97-171-5 |
Silane, diphenyl(2,4-dimethylpent-3-yloxy)hexadecyloxy-
|
| 538.92 |
| 98-905-9 |
Silane, diphenyl(2-decyloxy)tridecyloxy-
|
| 538.92 |
| 98-906-8 |
Silane, diphenyl(3-methylbut-2-yloxy)octadecyloxy-
|
| 538.92 |
| 98-904-0 |
Silane, diphenylheptadecyloxy(hex-2-yloxy)-
|
| 538.92 |
| 98-907-7 |
Silane, diphenylheptadecyloxy(2-methylpent-3-yloxy)-
|
| 538.92 |
| 98-901-3 |
Silane, diphenylpentadecyloxy(2,4,4-trimethylpentyloxy)-
|
| 538.92 |
| 98-900-4 |
Silane, diphenyl(hept-2-yloxy)hexadecyloxy-
|
| 538.92 |
| 86-432-7 |
Radicicol, tris(trimethylsilyl) ether
|
| 538.94 |
| 114-240-8 |
Isobutyl glucuronide, TMS
|
| 538.97 |
| 120-075-5 |
(R)-2-Butyl glucuronide, TMS
|
| 538.97 |
| 124-814-0 |
(S)-2-Butyl glucuronide, TMS
|
| 538.97 |
| 116-273-0 |
Butyl glucuronide, TMS
|
| 538.97 |
| 49-794-7 |
1-(2-(Hexadecyloxy)ethoxyl)octadecane
|
| 538.97 |
| 11-365-4 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, methyloxime (anti)
|
| 538.97 |
| 19-012-7 |
N-Acetyl-D-glucosamine, tetrakis(trimethylsilyl) ether, methyloxime (syn)
|
| 538.97 |
| 69-198-7 |
3«alpha»,16«alpha»,17«beta»-Trihydroxy'5«beta»-androstan-11-one, tris-TMS
|
| 538.98 |
| 69-239-1 |
Octacosanoic acid, TBDMS
|
| 539.00 |
| 97-164-3 |
Silane, methylvinyl(hexadecyloxy)pentadecyloxy-
|
| 539.00 |
| 54-432-2 |
5«beta»-Pregnane-3«alpha»,11«beta»,20«alpha»-triol, EO-TMS
|
| 539.03 |
| 70-658-4 |
5«alpha»-Pregnane-3«alpha»,11«beta»,20«alpha»-triol, EO-TMS
|
| 539.03 |
| 59-355-3 |
5«beta»-Pregnane-3«alpha»,16«alpha»,20«alpha»-triol, EO-TMS
|
| 539.03 |
| 47-782-2 |
Silane, (dotriacontyloxy)trimethyl-
|
| 539.05 |
| 72-490-8 |
A-Tagatopyranose, TMS
|
| 539.09 |
| 52-030-0 |
Adenosine, 2'-deoxy-N-(trifluoroacetyl)-, 3',5'-bis(trifluoroacetate)
|
35170-10-6 | 539.27 |
| 34-660-1 |
l-Tyrosine, N,O-bis(3-trifluoromethylbenzoyl)-, methyl ester
|
| 539.42 |
| 47-215-1 |
l-Tyrosine, N,O-bis(2-trifluoromethylbenzoyl)-, methyl ester
|
| 539.42 |
| 125-038-1 |
Diethylmalonic acid, 4-bromophenyl hexadecyl ester
|
| 539.59 |
| 68-724-3 |
Glutaric acid, 2-bromobenzyl heptadecyl ester
|
| 539.59 |
| 125-100-1 |
Diethylmalonic acid, 3-bromobenzyl pentadecyl ester
|
| 539.59 |
| 61-282-1 |
Glutaric acid, monoamide, N-(3,5-di(trifluoromethyl)benzyl)-, tridecyl ester
|
| 539.59 |
| 116-873-4 |
L-Proline, N-(3-trifluoromethylbenzoyl)-, octadecyl ester
|
| 539.71 |
| 123-743-0 |
L-Proline, N-(2-trifluoromethylbenzoyl)-, octadecyl ester
|
| 539.71 |
| 98-998-7 |
DL-Valine, N-methyl-N-decyloxycarbonyl-, hexadecyl ester
|
| 539.87 |
| 97-231-8 |
DL-Valine, N-methyl-N-(2-ethylhexyloxycarbonyl)-, octadecyl ester
|
| 539.87 |
| 33-243-5 |
dl-Metanephrine, N,O,O'-(tert-butyldimethylsilyl)-
|
| 540.01 |
| 21-553-4 |
2-Deoxyglucose, MO-TMS
|
| 540.08 |
| 47-629-2 |
L-(-)-Fucose, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
| 540.08 |
| 70-126-4 |
L-(+)-Rhamnose, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
| 540.08 |
| 56-982-0 |
[2H]Glucosamine, TMS
|
| 540.08 |
| 42-001-3 |
L-(-)-Fucose, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 1)
|
| 540.08 |
| 70-156-1 |
L-(+)-Rhamnose, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 1)
|
| 540.08 |
| 72-470-0 |
Phthalic acid, di(2-bromo-5-fluorobenzyl) ester
|
| 540.15 |
| 36-292-8 |
Cu-TETMP complex
|
| 540.20 |
|
« Previous Results
Next Results »
|